SVF Investments (UK) Ltd
CIK 1716729 · last filed 2024-03-14
SVF Investments (UK) Ltd is a corporate insider who has filed 15 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for CPNG, was dated Aug 20, 2025. Across all open-market trades the lifetime net is −$1.55B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.99B across reported positions. The firm reports its address in London, X0. 28 SEC filings were submitted jointly with SVF Holdings (UK) LLP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.99B
4
15
-$1.55B
Filer Profile
LONDON, X0 W1K3JP
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPNG | 10%+ Owner | 349,542,259 | $14.29 | $4.99B | -$1.79B | 1 | 2024-03-14 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,791,378 | $16.24 | $370.13M | $151.22M | 3 | 2019-06-06 |
| Myovant Sciences Ltd. (MYOV) Delisted | 10%+ Owner | 38,341,357 | $26.98 | $1.03B | $90.00M | 1 | 2018-04-04 |
| ABUS | 10%+ Owner | — | $5.01 | — | $0 | 1 | 2017-10-17 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-20 | CPNG | Notice (144) | −20,000,000 | -$576.80M | EDGAR |
| 2025-06-13 | CPNG | Notice (144) | −10,000,000 | -$283.10M | EDGAR |
| 2025-05-08 | CPNG | Notice (144) | −30,000,000 | -$798.00M | EDGAR |
| 2024-03-14 | CPNG | Sell (S) | −93,228,308 | -$1.79B | EDGAR |
| 2024-03-13 | CPNG | Notice (144) | −15,000,000 | -$290.70M | EDGAR |
| 2024-03-12 | CPNG | Notice (144) | −31,614,154 | -$612.37M | EDGAR |
| 2023-11-29 | CPNG | Notice (144) | −30,000,000 | -$483.30M | EDGAR |
| 2023-09-28 | ROIV | Notice (144) | −10,000,000 | -$131.90M | EDGAR |
| 2019-06-06 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +84,488 | $663.8K | EDGAR |
| 2019-06-03 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +70,984 | $555.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.